Marianne J Davies, DNP, ACNP-BC, AOCNP-BC
Assistant Professor
Oncology Nurse Practitioner
Yale Cancer Center
New Haven, Connecticut
Roy S Herbst, MD, PhD
Ensign Professor of Medicine (Oncology)
Professor of Pharmacology
Chief of Medical Oncology
Director, Thoracic Oncology Research Program
Associate Director for Translational Research
Yale Comprehensive Cancer Center
Yale School of Medicine
New Haven, Connecticut
Please join us for a Pharmacyclics LLC, an AbbVie company, and Janssen Biotech, Inc. presentation of IMBRUVICA® (ibrutinib). Karolina Faysman, NP, RN, MSN, ONP, from UCLA Medical Center, will discuss IMBRUVICA®.
Co-Chairs
Patrick Forde, MD
Assistant Professor of Oncology
Johns Hopkins University
Baltimore, MD
Joanne Riemer, RN, BSN
Johns Hopkins University
Baltimore, MD
Faculty
Jason Luke, MD, FACP
Assistant Professor of Medicine
The University of Chicago Medicine
Chicago, IL
Karen Matijevich, RN
The University of Chicago Medicine
Chicago, IL
Chair
Richard J. Gralla, MD, FACP
Professor of Medicine
Albert Einstein College of Medicine
Jacobi Medical Center
Bronx, NY
Faculty
Rebecca Clark-Snow, RN, BSN, OCN
Clinical Nurse Coordinator
The University of Kansas Cancer Center
Westwood, KS
Cynthia N. Rittenberg, RN, MN, AOCN, FAAN
Rittenberg Oncology Consulting
Metairie, LA
Co-Chairs
Benjamin Levy, MD
Assistant Professor, Icahn School of Medicine
Medical Director, Thoracic Oncology Program, Mount Sinai Health Systems
Associate Director, Cancer Clinical Trials Office, Mount Sinai Hospital
Mount Sinai Hospital
New York, NY
Karen Lee, MSN, FNP-BC
Mount Sinai Hospital
New York, NY
Faculty
Laura Brennan FNP-c, AOCNP
Division of Hematology & Oncology
UC Davis Medical Center
Sacramento, CA
Ann Culkin, RN, OCN
Department of Nursing
Office Practice Nurse, Outpatient Thoracic Service
Memorial Sloan Kettering Cancer Center
New York, NY
Alexander E. Drilon, MD
Thoracic Oncology Service
Department of Medicine
Memorial Sloan Kettering Cancer Center
New York, NY
Jonathan Riess, MD, MS
Assistant Professor of Medicine
Division of Hematology Oncology
UC Davis Comprehensive Cancer Center
Sacramento, CA
Please join us for a breakfast symposium and overview of LONSURF® (trifluridine and tipiracil) hosted by Taiho Oncology. Mollie Reed, MSN RN ACNP-BC, from Tennessee Oncology in Nashville, Tennessee, will discuss LONSURF® and provide key information regarding this oral chemotherapy. We hope you will join us for this engaging event.
Sponsored by Taiho OncologyThis activity is supported by educational grants from Amgen Inc, Genentech BioOncology, Merck, and Novartis Pharmaceuticals Corporation.
Objectives: